Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001140361-19-013355

10% owner acquired 1,785,714 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
GLAXOSMITHKLINE PLC 10% owner 2019-07-22 Conversion +1,785,714 1,785,714 I
Derivatives
GLAXOSMITHKLINE PLC 10% owner 2019-07-22 Conversion · Series B Preferred Stock −12,500,000 0 I
Loading xslF345X03/form4.xml…